Takeda Pharmaceutical (TAK) Total Current Liabilities: 2018-2025
- Takeda Pharmaceutical's Total Current Liabilities rose 5.26% to $16.4 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $16.4 billion, marking a year-over-year increase of 5.26%. This contributed to the annual value of $16.5 billion for FY2025, which is 2.59% up from last year.
- According to the latest figures from Q1 2025, Takeda Pharmaceutical's Total Current Liabilities is $16.4 billion, which was up 5.26% from $15.6 billion recorded in Q1 2024.
- Over the past 5 years, Takeda Pharmaceutical's Total Current Liabilities peaked at $18.8 billion during Q1 2023, and registered a low of $15.6 billion during Q1 2024.
- Over the past 3 years, Takeda Pharmaceutical's median Total Current Liabilities value was $16.4 billion (recorded in 2025), while the average stood at $16.9 billion.
- As far as peak fluctuations go, Takeda Pharmaceutical's Total Current Liabilities increased by 10.22% in 2022, and later decreased by 16.81% in 2024.
- Over the past 5 years, Takeda Pharmaceutical's Total Current Liabilities (Quarterly) stood at $16.8 billion in 2021, then grew by 10.22% to $18.5 billion in 2022, then rose by 1.62% to $18.8 billion in 2023, then dropped by 16.81% to $15.6 billion in 2024, then grew by 5.26% to $16.4 billion in 2025.
- Its Total Current Liabilities stands at $16.4 billion for Q1 2025, versus $15.6 billion for Q1 2024 and $18.8 billion for Q1 2023.
